Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Urologia Internationalis|August 27, 2005
Importance of urinary interleukin-18 in intravesical immunotherapy with bacillus calmette-guérin for superficial bladder tumorsMasatoshi Eto, Hirofumi Koga, Hideya Noma, et al.
International Journal of Clinical Oncology|August 26, 2019
An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancerTomohiro Tsuchiya, Keiichiro Imanaka, Yuki Iwaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 17, 2007
A pilot study of the assessment of the quality of life, functional results, and complications in patients with an ileal neobladder for invasive bladder cancerMasahiko Harano, Masatoshi Eto, Motonobu Nakamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 2005
Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladderHirofumi Koga, Masao Kuroda, Seiji Kudo, et al.
Cancer Science|August 14, 2014
Phase-1 study of abiraterone acetate in chemotherapy-naïve Japanese patients with castration-resistant prostate cancerNobuaki Matsubara, Hiroji Uemura, Iwao Fukui, et al.
The Journal of Urology|December 14, 2007
Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancerSeiji Naito, Hirofumi Koga, Akito Yamaguchi, et al.
Anticancer Research|August 2, 2019
Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder CancerMasakazu Akitake, Akito Yamaguchi, Masaki Shiota, et al.
Pageof 5